Analyst Price Targets — SBRA
Latest News for SBRA
Amundi increased its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 22.7% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 182,620 shares of the real estate investment trust's stock after buying an additional 33,787 shares during
Wall Street analysts made some dramatic moves on Thursday, slashing price targets by double digits on several high-profile names while upgrading others to buy. Find out which stocks got the most surprising treatment before the opening bell.
Sabra Health Care REIT, Inc. (SBRA) Q2 2026 Earnings Call Transcript
Sabra Healthcare REIT NASDAQ: SBRA reported second-quarter 2026 normalized funds from operations of $0.38 per share and normalized adjusted funds from operations of $0.40 per share, with management reaffirming the higher full-year earnings outlook it issued in a July business update.
Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.4 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to FFO of $0.38 per share a year ago.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SBRA.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.